CMS Open Payments · Program Year 2024
Human Regenerative Technologies
Human Regenerative Technologies reported $118,750.00 across General Payments, Research, and Ownership to 60 physicians and teaching hospitals across 61 transactions.
- $118.8K Below-median payer
- All-tracks total
- 61 Below-median volume
- Transactions
- 60 Below-median reach
- Recipients
- #1140
- of 1,925 companies
Human Regenerative Technologies reported $118,750.00 across all CMS Open Payments tracks (General + Research + Ownership) to 60 physicians and teaching hospitals in Program Year 2024 - ranking #1140 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $64,750.00, averaging $2.0K per recipient.
How Human Regenerative Technologies's $118.8K all-tracks total breaks down
Human Regenerative Technologies's payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
10/100
Total payments
F
11/100
Transaction volume
F
10/100
Physician reach
F
10/100
Payment type diversity
F
10/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer human-regenerative-technologies Human Regenerative Technologies
$118.8K · #1140/1,925 · 0.0% industry · PY2024
- TOT $118.8K
- RANK #1140
- SHARE 0.0%
- TXN 61
- RCP 60
- CAT 1
- GEN $64.8K
- TOP1 34.3%
- PY 2024
Volume peers
Nearest volume peer: Noctrix Health, Inc. ($118.6K)
Human Regenerative Technologies sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
What the Data Shows for Human Regenerative Technologies
Three separate CMS disclosure tracks feed the all-tracks total above - General, Research, and Ownership/Investment - each reported under its own rules and combined here for one comparable figure. For Human Regenerative Technologies, that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. CMS releases each Program Year roughly 12 months after it ends; the methodology page covers the full standardization basis.
"Compensation for Services Other Than Consulting" leads the 1-category general-payment breakdown below at $64.8K (100.0% of General Payments, 60 transactions) - see our methodology for how research and ownership payments are reported separately.
General Payment Breakdown by Type
Across 1 types of general payments, Human Regenerative Technologies's largest category was "Compensation for Services Other Than Consulting" at $64.8K - 100.0% of General Payments.
How Human Regenerative Technologies divides its payments
How the reported total splits across payment categories
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Compensation for Services Other Than Consulting | $64.8K | 60 | 100.0% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $64,750.00 (100.0%) of $64,750.00 in this company's General Payments records across 5 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Human Regenerative Technologies
The five named recipients with the highest reported General Payments from this company
- 1
Kay May Kwok
$22,200.00 across 12 reported transactions
- 2
Steven Rosenberg
$14,650.00 across 12 reported transactions
- 3
Alexandra Bujor
$11,200.00 across 12 reported transactions
- 4
Ben Naghi
$10,700.00 across 12 reported transactions
- 5
Freya Marshall
$6,000.00 across 12 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Human Regenerative Technologies ranks #1140 of 1,925 by total payments (bottom 41% by spend) but is notably more concentrated than that alone would suggest -- #682 of 1,838 by HHI (top 37% most concentrated). Its payments land on an unusually narrow set of recipients for its spend size.
View all 12 companies in this HHI neighborhood as a list
- FloSpine LLC : $48.7K total payments, HHI 2372
- RedDress USA, Inc. : $184.0K total payments, HHI 2360
- Cornerstone Specialty Network LLC : $120.5K total payments, HHI 2356
- Osteoremedies, LLC : $396.8K total payments, HHI 2355
- Avertix Medical, Inc : $164.0K total payments, HHI 2352
- Ricoh USA, Inc. : $336.00 total payments, HHI 2347
- Human Regenerative Technologies (this company) : $64.8K total payments, HHI 2346
- Medical Microinstruments, Inc. : $113.0K total payments, HHI 2343
- Captiox LLC : $34.7K total payments, HHI 2342
- Visby Medical, Inc. : $73.4K total payments, HHI 2338
- RIWOspine, Inc. : $30.8K total payments, HHI 2333
- HAPPE Spine : $1.2K total payments, HHI 2328
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Human Regenerative Technologies's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Human Regenerative Technologies.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Human Regenerative Technologies.
Showing 6 of 1,924 companies with CMS-reported payment data.
Forte Bio-Pharma LLC
Brainlab, Inc.
Neptune Medical Inc.
Brixton Biosciences, Inc.
Jan Medical Inc.
Put this to use
Human Regenerative Technologies ranks #1140 of 1,925 by all-tracks total payments, led by "Compensation for Services Other Than Consulting".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Compensation for Services Other Than Consulting" spend across every manufacturer, not just Human Regenerative Technologies. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.